EFF sues CMS over deployment of Medicare prior authorization AI - healthexec.com
EFF has filed a lawsuit against CMS regarding the deployment of AI for Medicare prior authorization, raising concerns about compliance and potential biases in the system.
Aforeworn detected this change in the Healthcare AI Regulation (FDA / ONC) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Health systems, medical device companies, health tech startups, and digital health compliance teams. should confirm how it applies to their specific situation before acting. There is a time constraint attached: N/A. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Healthcare AI Regulation (FDA / ONC) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Legal action has been initiated against CMS, which may affect the deployment and compliance of AI technologies in Medicare prior authorization processes.
Who it affects
Health systems, medical device companies, health tech startups, and digital health compliance teams.
What you must do
Review AI deployment strategies and ensure compliance with existing regulations while monitoring the lawsuit's progress.
Deadline
N/A
Never miss a change like this again
Aforeworn watches Healthcare AI Regulation (FDA / ONC) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Healthcare AI Regulation (FDA / ONC)
- Louisiana AI Legislative Update - pelicanpolicy.org
- New law aims to curb medical debt, increase transparency in hospital billing - indianapolisrecorder.com
- Illinois’ new AI therapy ban has a loophole - KevinMD.com
- New bill aims to safeguard health care licensing in Delaware - delawareonline.com
- FDA Grants Premarket Approval to AI-Enabled System for Breast Cancer Margin Assessment - targetedonc.com